NO20041651L - Anvendelse av (11 beta,17 beta)-11-(1,3-benzodioksol-5-yl)-17-hydroksy-17-(1-propynyl)-ostra-4,9-dien-3-on for behandling av alvorlig depressiv forstyrrelse - Google Patents

Anvendelse av (11 beta,17 beta)-11-(1,3-benzodioksol-5-yl)-17-hydroksy-17-(1-propynyl)-ostra-4,9-dien-3-on for behandling av alvorlig depressiv forstyrrelse

Info

Publication number
NO20041651L
NO20041651L NO20041651A NO20041651A NO20041651L NO 20041651 L NO20041651 L NO 20041651L NO 20041651 A NO20041651 A NO 20041651A NO 20041651 A NO20041651 A NO 20041651A NO 20041651 L NO20041651 L NO 20041651L
Authority
NO
Norway
Prior art keywords
beta
benzodioxol
dien
propynyl
hydroxy
Prior art date
Application number
NO20041651A
Other languages
English (en)
Other versions
NO332978B1 (no
Inventor
Cornelis Sennef
Nernardus Wijnand Math Peeters
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20041651L publication Critical patent/NO20041651L/no
Publication of NO332978B1 publication Critical patent/NO332978B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Foreliggende oppfinnelse angår anvendelse av glukokortikoidreseptorantagonisten (lip,17P)-ll-(l,3-benzodioksol-5-yl)-17-hydroksy-17-(lpropynyl)-østra-4,9-dien-3-on (Org 34517) for fremstilling av et medikament for behandling av depresjon så vel som farmasøytiske preparater av Org 34517 for nevnte anvendelse.
NO20041651A 2001-10-26 2004-04-23 Anvendelse av (11ß,17ß)-11-(1,3-benzodioksol-5-yl)-17-hydroksy-17-(1-propynyl)-ostra-4,9-dien-3-on for behandling av alvorlig depressiv forstyrrelse NO332978B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204072 2001-10-26
PCT/EP2002/011732 WO2003037354A1 (en) 2001-10-26 2002-10-21 USE OF (11β, 17β)-11-(1,3-BENZODIOXOL-5-YL)-17-HYDROXY-17-(1-PROPYNYL)-ESTRA-4,9-DIEN-3-ONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER

Publications (2)

Publication Number Publication Date
NO20041651L true NO20041651L (no) 2004-04-23
NO332978B1 NO332978B1 (no) 2013-02-11

Family

ID=8181136

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041651A NO332978B1 (no) 2001-10-26 2004-04-23 Anvendelse av (11ß,17ß)-11-(1,3-benzodioksol-5-yl)-17-hydroksy-17-(1-propynyl)-ostra-4,9-dien-3-on for behandling av alvorlig depressiv forstyrrelse

Country Status (27)

Country Link
US (1) US20040266863A1 (no)
EP (2) EP1441739B1 (no)
JP (1) JP4647909B2 (no)
KR (1) KR20050038580A (no)
CN (1) CN100531738C (no)
AT (2) ATE420649T1 (no)
AU (1) AU2002348996B2 (no)
BR (1) BR0213466A (no)
CA (1) CA2463446C (no)
CY (1) CY1110173T1 (no)
DE (2) DE60230936D1 (no)
DK (1) DK1652526T3 (no)
EC (1) ECSP045080A (no)
ES (1) ES2319563T3 (no)
HK (1) HK1087357A1 (no)
HR (1) HRP20040370B1 (no)
HU (1) HUP0500070A3 (no)
IL (2) IL161248A0 (no)
IS (1) IS2702B (no)
MX (1) MXPA04003781A (no)
NO (1) NO332978B1 (no)
NZ (1) NZ532429A (no)
PL (1) PL206687B1 (no)
PT (1) PT1652526E (no)
RU (1) RU2302245C2 (no)
WO (1) WO2003037354A1 (no)
ZA (1) ZA200403088B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080061A1 (en) * 2003-07-23 2005-04-14 Corcept Therapeutics, Inc. Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
MX2007006045A (es) * 2004-11-19 2007-06-13 Organon Nv Combinacion farmaceutica que comprende inhibidor selectivo de reabsorcion de serotonina y antagonista del receptor de glucocorticoide para tratamiento de depresion.
AU2011236053B2 (en) * 2004-11-19 2014-06-26 Merck Sharpe & Dohme B.V. Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
EP2012796A4 (en) * 2006-05-02 2010-08-11 Corcept Therapeutics Inc USE OF GLUCOCORTICOID TYPE II RECEPTOR ANTAGONISTS TO TREAT PATIENT DEPRESSION WITH IL-2
WO2012106514A2 (en) * 2011-02-03 2012-08-09 Pop Test Cortisol Llc System and method for diagnosis and treatment
US20120263660A1 (en) * 2011-04-18 2012-10-18 Pop Test Cortisol Llc Hair Loss Treatment
US8986677B2 (en) * 2012-07-30 2015-03-24 Pop Test Cortisol Llc Therapeutic compositions and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814333A (en) * 1987-07-28 1989-03-21 The Trustees Of Dartmouth College Method for treatment of hypercortisolemic, depressed patients
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
DE19727772A1 (de) * 1997-06-30 1999-01-28 Forschungszentrum Juelich Gmbh Magnetflußsensor mit ringförmiger Sonde
ATE332696T1 (de) * 1997-10-06 2006-08-15 Univ Leland Stanford Junior Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen
IL157770A0 (en) * 2001-03-23 2004-03-28 Corcept Therapeutics Inc Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
WO2002096433A1 (en) * 2001-05-04 2002-12-05 Corcept Therapeutics, Inc. Methods for treating delirium using glucocorticoid receptor-specific antagonists
EP1432379B1 (en) * 2001-08-31 2008-10-15 Corcept Therapeutics, Inc. Methods for inhibiting cognitive deterioration in adults with down's syndrome

Also Published As

Publication number Publication date
DK1652526T3 (da) 2009-05-18
PT1652526E (pt) 2009-02-06
DE60209248D1 (de) 2006-04-20
EP1441739B1 (en) 2006-02-15
HRP20040370B1 (en) 2012-09-30
CN100531738C (zh) 2009-08-26
NO332978B1 (no) 2013-02-11
CN1582153A (zh) 2005-02-16
KR20050038580A (ko) 2005-04-27
HK1087357A1 (en) 2006-10-13
EP1441739A1 (en) 2004-08-04
CA2463446C (en) 2010-02-23
IL161248A0 (en) 2004-09-27
ES2319563T3 (es) 2009-05-08
HUP0500070A3 (en) 2012-09-28
HUP0500070A2 (hu) 2005-04-28
EP1652526A3 (en) 2006-08-02
DE60230936D1 (de) 2009-03-05
PL369261A1 (en) 2005-04-18
BR0213466A (pt) 2004-11-09
EP1652526B1 (en) 2009-01-14
JP4647909B2 (ja) 2011-03-09
IL161248A (en) 2010-12-30
EP1652526A2 (en) 2006-05-03
CA2463446A1 (en) 2003-05-08
ZA200403088B (en) 2005-01-24
MXPA04003781A (es) 2004-07-30
JP2005521637A (ja) 2005-07-21
NZ532429A (en) 2004-10-29
IS2702B (is) 2010-11-15
PL206687B1 (pl) 2010-09-30
ATE420649T1 (de) 2009-01-15
AU2002348996B2 (en) 2008-06-05
RU2302245C2 (ru) 2007-07-10
WO2003037354A1 (en) 2003-05-08
ATE317700T1 (de) 2006-03-15
ECSP045080A (es) 2004-06-28
IS7204A (is) 2004-03-31
US20040266863A1 (en) 2004-12-30
RU2004116082A (ru) 2005-05-10
HRP20040370A2 (en) 2004-08-31
CY1110173T1 (el) 2015-01-14

Similar Documents

Publication Publication Date Title
NO20092730L (no) Selektiv ostrogenreseptormodulator i kombinasjon med dehydroeiandrosteron (DHEA) eller analoger
HUP0302093A2 (hu) Konjugált ösztrogének és medroxi-progeszteron-acetát alkalmazása hormonpótló terápiában használható gyógyszerkészítmény előállítására
CY1110173T1 (el) Χρηση της (11 beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one στη θεραπεια μειζωνος καταθλιπτικης διαταραχης
ATE493132T1 (de) Arzneimittel umfassend wenigstens ein gestagen
TR200100063T2 (tr) Androst-5-en-3ß,17ß-diol için farmasötik kompozisyonlar ve kullanımlar
ATE452641T1 (de) Orale pharmazeutische zusammensetzung enthaltend 15-hydroxytestosteron und seine derivate
HUP0301460A2 (hu) Antiprogresztinek használata hormonfüggő betegségek megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállításához
DE50308933D1 (de) Zusammensetzung, enthaltend ein androgenes 11-b-halogensteroid und ein gestagen sowie m nnliches kontrazeptivum auf basis dieser zusammensetzung
IL164159A0 (en) C-17 spirolactonization and 6,7 oxidation of steroids
HUP0500346A2 (hu) Konjugált ösztrogének alkalmazása ösztrogénpótó terápiában hatásos gyógyszerkészítmények előállítására
PT1421099E (pt) Esteres de 17-alfa, 21-di-hidroxipregneno como agentes anti-androgenicos
HUP0300626A2 (hu) Progesztogén és mifepriszton alkalmazása rákellenes gyógyszerkészítmények előállítására
IL139861A0 (en) 17β-AMINO-AND HYDROXYLAMINO -11 β-ARYLSTEROID DERIVATIVES, METHODS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
AR018313A1 (es) Kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, uso de un compuesto esteroide que tiene un perfil deactividad que combina inherentemente las actividades progestagenicas y estrogenicas y un metodo anticonceptivo
ATE419855T1 (de) Therapie für hormonersatz und depression enthaltend dienogest
ATE377020T1 (de) Kristallines gamma-lacton der17beta-hydroxy-
NO20022712D0 (no) Umettede 14,15-syklopropanandrostaner, fremgangsmåte for deres fremstilling, og farmasöytiske preparater som inneholderdisse forbindelsene

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees